Making the diagnosis of frontotemporal lobar degeneration

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 3, 2013, Pages 314-325

  Bigio, Eileen H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FRONTOTEMPORAL DEMENTIA; HUMAN;

FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS;

EID: 84874726228     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0075-RA     Document Type: Article

References (26)

1. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease: a primer for practicing pathologists. Arch Pathol Lab Med. 1993;117(2):132-144.
2. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), II: standardization of neuropathological assessment of Alzheimer's disease. Neurology. 1991;41(4):479-486.
3. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239-259.
4. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol. 1997;56(10):1095- 1097.
5. Montine TJ, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012;123(1):1-11.
6. Hyman BT, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 2012;8(1)1-13.
7. Alafuzoff I, Arzberger T, Al-Sarraj S, et al. Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol. 2008;18(4):484-496.
8. Alafuzoff I, Thal DR, Arzberger T, et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol. 2009;117(3):309-320.
9. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies; third report of the DLB Consortium. Neurology. 2005;65(12):1863-1872.
10. Ratnavalli E, Brayne C, Dawson K, Hodges Jr. The prevalence of frontotemporal dementia. Neurology. 2002;58(11):1615-1621.
11. Piquet O, Hornberger M, Mioshi E, Hodges Jr. Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol. 2011;10(2):162-172.
12. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006-1014.
13. Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II: clinical picture and differential diagnosis. Arch Gerontol Geriatr. 1987;6(3):209-223.
14. Cairns NJ, Bigio EH, Mackenzie IRA, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007; 114(1):5-22.
15. Mackenzie IRA, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119(1):1-4.
16. Bigio EH, Mishra M, Hatanpaa KJ, et al. TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Acta Neuropathol. 2010;120(1):43-54.
17. Dickson DW. Neuropathology of Pick's disease. Neurology. 2001; 56(suppl 4):S16-S20.
18. Garibotto V, Borroni B, Agosti C, et al. Subcortical and deep cortical atrophy in frontotemporal lobar degeneration. Neurobiol Aging. 2011;32(5):875-884.
19. Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathol. 2007;17(1):74-82.
20. Mitani K, Uchihara T, Tamaru F, Endo K, Tsukagoshi H. Corticobasal degeneration: clinico-pathological studies on two cases [in Japanese]. Rinsho Shinkeigaku. 1993;33(2):155-161.
21. Josephs KA, Dickson DW. Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration. Neurobiol Aging. 2007;28(11):1718-1722.
22. Thal DR, Rub U, Orantes M, Braak H. Phases of Abeta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002; 58(12):1791-1800.
23. de Silva R, Lashley T, Gibb G, et al. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol. 2003;29(3):288-302.
24. Arai N. "Grumose degeneration" of the dentate nucleus: a light an electron microscopic study in progressive supranuclear palsy and dentatorubropallidoluysial atrophy. J Neurol Sci. 1989;90(2):131-145.
25. Mackenzie IRA, Neumann M, Baborie A, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122(1):111-113.
26. Munoz DG, Neumann M, Kusaka H, et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol. 2009;118(5):617-627.